Phenolic compounds from Fagonia bruguieri show promise in diabetes treatment.
The researchers studied how a compound from Fagonia bruguieri affects the health of female rats, both healthy and diabetic. They divided the rats into different groups and gave them different treatments for 30 days. The results showed that the group injected with aloxane had higher sugar and Malondialdehyde levels, and lower seroplasmin and albumin levels. The groups treated with the F. bruguieri compound did not show significant differences in blood sugar levels compared to the control group. However, there were differences in Malondialdehyde, seroplasmin, and albumin levels among the groups. Cholesterol, triglycerides, LDL, and VLDL levels also increased significantly.